Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 202

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Development and validity testing of the neuropathy total symptom score-6: Questionnaire for the study of sensory symptoms of diabetic peripheral neuropathy

Bastyr, Edward J., Price, Karen L., Bril, Vera·2005·Clinical Therapeutics

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.clinthera.2005.08.002

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Research works printed but not linked: 45

  1. Maser, 1989, Epidemiological correlates of diabetic neuropathy. Report from Pittsburgh Epidemiology of Diabetes Complications Study, Diabetes, 38, 1456, 10.2337/diabetes.38.11.1456 · DOI
  2. Fedele, 1997, A multicenter study on the prevalence of diabetic neuropathy in Italy, Diabetes Care, 20, 836, 10.2337/diacare.20.5.836 · DOI
  3. Apfel, 2001, Positive neuropathic sensory symptoms as endpoints in diabetic neuropathy trials, J Neurol Sci, 189, 3, 10.1016/S0022-510X(01)00584-6 · DOI
  4. Harris, 1993, Symptoms of sensory neuropathy in adults with NIDDM in the US population, Diabetes Care, 16, 1446, 10.2337/diacare.16.11.1446 · DOI · Paper page
  5. Boulton, 1985, The prevalence of symptomatic, diabetic neuropathy in an insulin-treated population, Diabetes Care, 8, 125, 10.2337/diacare.8.2.125 · DOI
  6. Marchettini, 2004, Pain in diabetic neuropathy case study: Whole patient management, Eur J Neurol, 11, 12, 10.1111/j.1471-0552.2004.00795.x · DOI
  7. O'Hare, 1994, Prevalence and forms of neuropathic morbidity in 800 diabetics, Jr J Med Sci, 163, 132, 10.1007/BF02965972 · DOI
  8. Hong, 1998, Neuropathy in non-insulin-dependent diabetes mellitus. The significance of symptoms, Scand J Prim Health Care, 16, 233
  9. Valk, 1994, Complaints of neuropathy related to the clinical and neurophysiological assessment of nerve function in patients with diabetes mellitus, Diabetes Res Clin Pract, 26, 29, 10.1016/0168-8227(94)90136-8 · DOI
  10. 2005, Standards of medical care in diabetes (Position Statement), Diabetes Care, 28, S4
  11. Bastyr, 2002, Neuropathy Total Symptom Score-6 Questionnaire (NTSS-6) is a valid instrument for assessing the positive symptoms of diabetic peripheral neuropathy (DPN), Diabetes, 51, A199
  12. Scott, 1976, Graphic representation of pain, Pain, 2, 175, 10.1016/0304-3959(76)90113-5 · DOI · Paper page
  13. Dyck, 2002, Electronic case-report forms of symptoms and impairments of peripheral neuropathy, Can J Neurol Sci, 29, 258, 10.1017/S0317167100002043 · DOI
  14. Backonja, 1998, Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: A randomized controlled trial, JAMA, 280, 1831, 10.1001/jama.280.21.1831 · DOI · Paper page
  15. Rowbotham, 2004, Venlafaxine extended release in the treatment of painful diabetic neuropathy: A double-blind, placebo-controlled study, Pain, 110, 697, 10.1016/j.pain.2004.05.010 · DOI · Paper page
  16. Goldstein, 2005, Duloxetine vs placebo in patients with painful diabetic neuropathy, Pain, 116, 109, 10.1016/j.pain.2005.03.029 · DOI · Paper page
  17. Melzack, 1975, The McGill Pain Questionnaire: Major properties and scoring methods, Pain, 1, 277, 10.1016/0304-3959(75)90044-5 · DOI · Paper page
  18. Galer, 2002, The lidocaine patch 5% effectively treats all neuropathic pain qualities: Results of a randomized, double-blind, vehicle-controlled, 3-week efficacy study with use of the neuropathic pain scale, Clin J Pain, 18, 297, 10.1097/00002508-200209000-00004 · DOI · Paper page
  19. Keller, 2004, Validity of the brief pain inventory for use in documenting the outcomes of patients with noncancer pain, Clin J Pain, 20, 309, 10.1097/00002508-200409000-00005 · DOI · Paper page
  20. Feldman, 1994, A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy, Diabetes Care, 17, 1281, 10.2337/diacare.17.11.1281 · DOI · Paper page
  21. Cornblath, 1999, Total neuropathy score: Validation and reliability study, Neurology, 53, 1660, 10.1212/WNL.53.8.1660 · DOI · Paper page
  22. Patrick, 1999, Quality of life of women with urinary incontinence: Further development of the incontinence quality of life instrument (I-QOL), Urology, 53, 71, 10.1016/S0090-4295(98)00454-3 · DOI · Paper page
  23. Lohr, 1996, Evaluating quality-of-life and health status instruments: Development of scientific review criteria, Clin Ther, 18, 979, 10.1016/S0149-2918(96)80054-3 · DOI · Paper page
  24. Vickrey, 2000, Development of a health-related quality of life measure for peripheral neuropathy, Neurorehabil Neural Repair, 14, 93, 10.1177/154596830001400202 · DOI
  25. Ziegler, 1999, Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: A 7-month multicenter randomized controlled trial (ALADIN III Study). Alpha-Lipoic Acid in Diabetic Neuropathy, Diabetes Care, 22, 1296, 10.2337/diacare.22.8.1296 · DOI · Paper page
  26. Masson, 1989, A novel approach to the diagnosis and assessment of symptomatic diabetic neuropathy, Pain, 38, 25, 10.1016/0304-3959(89)90068-7 · DOI
  27. Galer, 2000, Painful diabetic polyneuropathy: Epidemiology, pain description, and quality of life, Diabetes Res Clin Pract, 47, 123, 10.1016/S0168-8227(99)00112-6 · DOI · Paper page
  28. Vrethem, 2002, Painful polyneuropathy in patients with and without diabetes: Clinical, neurophysiologic, and quantitative sensory characteristics, Clin J Pain, 18, 122, 10.1097/00002508-200203000-00008 · DOI
  29. Benbow, 1999, Painful diabetic neuropathy, Diabet Med, 16, 632, 10.1046/j.1464-5491.1999.00028.x · DOI
  30. Perrin, 2004, The reliability and validity of a self-administered version of the neuropathy total symptom score-6-SA (NTSS-6-SA), Diabetologia, 47, A35
  31. Brown, 2004, The prevalence and characteristics of type 2 diabetes mellitus patients with positive sensory symptoms of diabetic peripheral neuropathy, Diabetes, 53, A508
  32. Dyck, 2000, Patterns of quantitative sensation testing of hypoesthesia and hyperalgesia are predictive of diabetic polyneuropathy: A study of three cohorts, Diabetes Care, 23, 510, 10.2337/diacare.23.4.510 · DOI · Paper page
  33. 1997, Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, Diabetes Care, 20, 1183, 10.2337/diacare.20.7.1183 · DOI · Paper page
  34. Dyck, 1988, Detection, characterization, and staging of polyneuropathy: Assessed in diabetics, Muscle Nerve, 11, 21, 10.1002/mus.880110106 · DOI · Paper page
  35. Dyck, 1995, Variables influencing neuropathic endpoints: The Rochester Diabetic Neuropathy Study of Healthy Subjects, Neurology, 45, 1115, 10.1212/WNL.45.6.1115 · DOI · Paper page
  36. Vinik, 2002, LY333531 treatment improve diabetic peripheral neuropathy (DPN) with symptoms, Diabetes, 51, A79
  37. Kulseng-Hanssen, 2003, The development of a questionnaire to measure the severity of symptoms and the quality of life before and after surgery for stress incontinence, BJOG, 110, 983, 10.1111/j.1471-0528.2003.01406.x · DOI
  38. Dyck, 1997, Longitudinal assessment of diabetic polyneuropathy using a composite score in the Rochester Diabetic Neuropathy Study cohort, Neurology, 49, 229, 10.1212/WNL.49.1.229 · DOI · Paper page
  39. Nelsen, 1999, Quality-of-life questionnaire for patients taking antihypertensive medication, Clin Ther, 21, 1771, 10.1016/S0149-2918(99)80055-1 · doi:10.1016/s0149-2918(99)80055-1
  40. Landis, 1977, The measurement of observer agreement for categorical data, Biometrics, 33, 159, 10.2307/2529310 · DOI · Paper page
  41. Ametov, 2003, The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: The SYDNEY trial, Diabetes Care, 26, 770, 10.2337/diacare.26.3.770 · DOI · Paper page
  42. Vinik, 2005, Treatment of symptomatic diabetic peripheral neuropathy with the protein kinase C β-inhibitor ruboxistaurin mesylate during a 1-year, randomized, placebo-controlled, double-blind clinical trial, Clin Ther, 27, 1164, 10.1016/j.clinthera.2005.08.001 · DOI · Paper page
  43. Hotta, 2001, Clinical efficacy of Fidarestat, a novel aldose reductase inhibitor, for diabetic peripheral neuropathy: A 52-week multi-center placebo-controlled double-blind parallel group study, Diabetes Care, 24, 1776, 10.2337/diacare.24.10.1776 · DOI · Paper page
  44. Dyck, 1986, Neuropathy Symptom Profile in health, motor neuron disease, diabetic neuropathy, and amyloidosis, Neurology, 36, 1300, 10.1212/WNL.36.10.1300 · DOI
  45. 1985, Rating scales and assessment instruments for use in pediatric psychopharmacology research, Psychopharmacol Bull, 21, 714

Cited by

See all 202

Metadata

Authors
Bastyr, E. J., Price, K. L., & Bril, V.
Venue
Clinical Therapeutics
Publisher
Elsevier BV
Published
2005-08
Volume
27
Issue
8
Pages
1278-1294
ISSN
0149-2918 (ISSN-L)
OpenAlex
W2085309918
Cited by
202
References
8
FWCI
4.01
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Development and validity testing of the neuropathy total symptom score-6: Questionnaire for the study of sensory symptoms of diabetic peripheral neuropathy. https://app.cochat.ai/papers/10.1016/j.clinthera.2005.08.002
The paper
Bastyr, E. J., Price, K. L., & Bril, V. (2005). Development and validity testing of the neuropathy total symptom score-6: Questionnaire for the study of sensory symptoms of diabetic peripheral neuropathy. Clinical Therapeutics. https://doi.org/10.1016/j.clinthera.2005.08.002

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.